D. Salvadori

Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.

Deepak L. Bhatt, M. Leon, S. King, 2013, JAMA.

DNA repair gene polymorphism is associated with the genetic basis of atherosclerotic coronary artery disease.

G. N. da Silva, E. A. de Camargo, D. Salvadori, 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[Percutaneous transluminal coronary angioplasty in a patient with idiopathic thrombocytopenic purpura].

D. Salvadori, J. Quiñones, V. Franco, 2005, Arquivos brasileiros de cardiologia.

POLAR registry (Promus eluting stent registry in Latin America ):1 year follow-up results

F. Feres, A. Abizaid, J. Mangione, 2012 .

Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomized, multicenter study.

Deepak L. Bhatt, M. Leon, S. King, 2012, American heart journal.